Fibrovein
FibroveinTM has been used worldwide since 1946 in the treatment of varicose veins. It is a detergent-based sclerosant injection comprised of Sodium Tetradecyl Sulphate (STS).
Fibrovein can be used for treatment of uncomplicated primary varicose veins, recurrent or residual veins following surgery, reticular veins, and spider veins of the lower extremities.
Research dictates that treatment using Fibrovein is an effective form of sclerotherapy. Occlusion rates following the procedure were 83-89.9% effective at follow up appointments over eight weeks to five years.1,2,3
Four different concentrations of Fibrovein; 3%, 1%, 0.5% and 0.2%, are available for purchase dependant on the size of the vein in treatment. This allows for wider use of the product for patients with varying requirements.
For more information on the mechanism of action and post-treatment
information see the product brochure below.
References
1. Beckitt T, Elstone A, Ashley S. Air versus Physiological Gas for Ultrasound Guided Foam Sclerotherapy Treatment of Varicose Veins. Eur J Vasc Endovasc Surg; 2011; 42: 115-119
2. Bradbury A et al. Ultrasound-guided foam sclerotherapy is a safe and clinically effective treatment for superficial venous reflux. J Vasc Surg 2010; 52(4): 939-945
3. Coleridge Smith P. Chronic Venous Disease Treated by Ultrasound Guided
Foam Sclerotherapy. Eur J Vasc Endovasc Surg 2006; 32(5): 577-583.